CPHI to launch new North American edition in May 2017

New event will cover full pharmaceutical value chain, bringing together key buyers and sellers of pharmaceutical ingredients, contract services, packaging, machinery/technology, finished dosage formulations and bio services within the North American market.

The launch of this event comes at an ideal time as the industry continues to experience massive growth. The North American generic pharmaceuticals market stands as the largest globally, valued at $71.8 billion, with expected growth of 3–6% annually between 2016 and 2020. On a larger scale, the global market for pharmaceutical contract research and manufacturing services (PCRAMS) is set to grow by an average of 13.6% each year through 2017, by which time it will be worth a staggering $136 billion.

“CPHI North America will provide an unrivalled opportunity to become a key stakeholder in a leading pharma landscape,” said CPHI North America Portfolio Director, Robyn Duda. “With the projected growth of the pharma industry in this region, there isn’t a better time to bring such an established pharmaceutical event to North America in 2017.”

CPHI North America will bring the entire pharmaceutical value chain together at one time to serve as the platform for thought leadership, partnerships and innovation in the North American pharmaceutical industry. The event will offer exclusive networking and educational opportunities, including an onsite conference program hosted in partnership with CBI, the leading life science conference producer. The event will focus first and foremost on the buying and selling of pharmaceutical ingredients and APIs. In addition to ingredients, conference verticals will include contract services, packaging, machinery/technology, finished dosage formulation and biopharmaceuticals.

Dedicated show floor zones will deliver the most relevant buyers

To serve the needs of the North American pharmaceutical supply chain the following brands, affiliated with CPHI Worldwide, will comprise the zoned show floor.

• CPHI North America will focus on pharmaceutical ingredients with exhibiting companies covering ingredients, APIs, excipients and more.

• ICSE will connect the pharmaceutical community with outsourcing solution providers.

• InnoPack will offer innovative and diverse drug delivery solutions to satisfy the changing way in which medication is packaged and delivered.

• FDF will bring every aspect of the finished dosage supply chain together, from Big Pharma and CMO, to out-licensing specialists, end product distributors, end user agents and home markets.

“It has been tremendous hearing firsthand the positive reaction from customers, associations and business partners alike regarding this new regional addition of the CPHI brand in North America,” commented Rutger Oudejans, Brand Director, UBM EMEA, Pharma Portfolio, about the positive feedback from the industry. “The feedback reinforces this exciting launch as a key platform for doing business in the US pharma market and indeed the biggest pharmaceutical market in the world!”